Close

Notable Analyst Rating Changes 06/15: (NTAP) (ARUN) (FIG) Upgraded; (CPST) (MYGN) (SOL) Downgraded Jun 15, 2011 10:34AM
UBS Maintains a 'Neutral' on Myriad Genetics (MYGN); Upside FQ3 & A Pathway To Diversification May 4, 2011 01:12PM
Notable Analyst Rating Changes 05/04: (FSLR) (SNY) (FE) Upgraded; (MEE) (NSC) (MYL) Downgraded May 4, 2011 10:54AM
Daily State of the Markets 01/28: Big, Round Numbers Jan 28, 2011 09:28AM
UBS Maintains a 'Neutral' on Myriad Genetics (MYGN); A $0.01 EPS Beat, But Sales Fall Just Short Nov 3, 2010 10:57AM


Aug 11, 2010 11:17AM Notable Analyst Rating Changes 08/11: LDK, BPO, SPWRA, NRGY Upgraded; MYGN, PBR, TWTC, TSCO Downgraded
Aug 2, 2010 12:15PM UBS Lowers Price Target On Myriad Genetics (MYGN) to $16
May 6, 2010 08:19AM UBS Downgrades Myriad Genetics (MYGN) to Neutral
Jan 12, 2010 10:51AM Notable Analyst Rating Changes 1/12: PG, MGM, DPZ, CMA, QLGC, WGOV Upgraded; CL, GPS, NWY, PMCS, LEAP, MYGN Downgraded
Nov 2, 2009 01:40PM Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
May 19, 2009 10:24AM Notable Analyst Rating Changes 5/19: THC, NFLX, AAP, GIL, CNW Upgraded; RF, APP, SPN Downgraded
Jun 30, 2008 09:27AM Pre-Open Movers 6/30: H&R Block (HRB) Up on Results/Guidance; Myriad Genetics (MYGN) Lower on Drug Failure